CCDC98 Peptide Reference: GTX85433-PEP CCDC98 peptide is used for blocking the activity of CCDC98 antibody (catalog number GTX85433). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human HB-EGF (Animal-Free) Reference: GFH180AF-100 Heparin-Binding Epidermal Growth Factor-like growth factor (HB-EGF) is a member of the Epidermal Growth Factor (EGF) family and is expressed by monocytes and macrophages. HB-EGF is the predominant growth factor involved in epithelialization during wound healing. HB-EGF signals through the receptor tyrosine kinase ErbB2 to maintain adult heart homeostasis and promotes cardiac valve development through binding in high affinity to the epidermal growth factor receptor (EGFR). HB-EGF binds the the ErbB4 receptor tyrosine kinase to mediate implantation of the human blastocyst. HB-EGF also functions as a potent mitogen for fibroblasts and smooth muscle cells.
STEAP3 Peptide Reference: GTX85434-PEP STEAP3 peptide is used for blocking the activity of STEAP3 antibody (catalog number GTX85434). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human HB-EGF (Animal-Free) Reference: GFH180AF-1000 Heparin-Binding Epidermal Growth Factor-like growth factor (HB-EGF) is a member of the Epidermal Growth Factor (EGF) family and is expressed by monocytes and macrophages. HB-EGF is the predominant growth factor involved in epithelialization during wound healing. HB-EGF signals through the receptor tyrosine kinase ErbB2 to maintain adult heart homeostasis and promotes cardiac valve development through binding in high affinity to the epidermal growth factor receptor (EGFR). HB-EGF binds the the ErbB4 receptor tyrosine kinase to mediate implantation of the human blastocyst. HB-EGF also functions as a potent mitogen for fibroblasts and smooth muscle cells.
STEAP2 Peptide Reference: GTX85435-PEP STEAP2 peptide is used for blocking the activity of STEAP2 antibody (catalog number GTX85435). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2a Reference: GFH54-20 Interferon-α 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.
SLPI Peptide Reference: GTX85436-PEP SLPI peptide is used for blocking the activity of SLPI antibody (catalog number GTX85436). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2a Reference: GFH54-100 Interferon-α 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.
TBC1D1 Peptide Reference: GTX85437-PEP TBC1D1 peptide is used for blocking the activity of TBC1D1 antibody (catalog number GTX85437). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2a Reference: GFH54-250 Interferon-α 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.
ORAI3 Peptide Reference: GTX85438-PEP ORAI3 peptide is used for blocking the activity of ORAI3 antibody (catalog number GTX85438). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2a Reference: GFH54-1000 Interferon-α 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.